中國鐵物(000927.SZ):下屬公司水泥熟料生產線項目建成投產
格隆匯11月25日丨中國鐵物(000927.SZ)宣佈,公司全資子公司中鐵物晟科技發展有限公司之全資子公司中國鐵路物資工業(集團)有限公司(簡稱“工業集團”)下屬全資子公司馬鞍山鐵鵬水泥有限公司日產4000噸水泥熟料生產線產能置換項目,已於近日建成並點火投產。
該項目投資概算6.34億元,通過淘汰落後產能,進行減量置換,實現技術升級。項目於2020年12月開工建設,提前一個多月高質量完成建設任務,投產後可新增水泥熟料年設計產能124萬噸,使工業集團總體水泥熟料年產能增至341萬噸。該項目的建成,對於工業集團充分利用現有礦山資源,擴大水泥生產的規模效應,開拓華東區域市場具有積極的意義。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.